Dear Sir,Dengue virus (DENV) has been listed on a catalogue from the American Association of Blood Banks (AABB) as transfusion transmissible infectious (TTIs) (Stramer et al., 2009). Routine screening for DENV RNA with nucleic acid testing (NAT) on donors' samples has been suggested to reduce the transfusion-transmitted risk of DENV in several countries and regions with high epidemic, such as Honduras (Linnen et al., 2008) and Brazil (Dias et al., 2012).In China, the third historically largest dengue hemorrhagic fever (DHF) outbreak spread throughout Guangdong province with 6024 confirmed DHF cases resulting in six deaths (Sun et al., 2016), as well as reported cases among 26 Chinese provinces (Lai et al., 2015) in 2014. The outbreak of DHF raised the increasing concern on DENV infection nationwide. However, the data on the DENV sero-prevalence and viremia status among blood donors were rare. A pilot investigation among asymptomatic donors in Guangzhou city (Guangdong province) during the epidemic outbreak (2014) reported that the anti-DENV IgM prevalence rate was 2·4% (n = 3000) (Rong et al., 2015), indicating a potential transfusion-transmitted risk. The sero-prevalence and viremia rate of DENV in blood donors from Guangzhou post the epidemic outbreak should be investigated.From April to October 2015, 1164 whole blood and apheresis donors who passed the routine pre-donation screening process were recruited during the routine donation process from the Guangzhou blood centre. Donor samples from the first 3 weeks of each month during the study period (n = 819) were selected and tested both for anti-DENV IgG and IgM using capture ELISA kits from Panbio (Brisbane, Australia), in which 34 were positive for IgG and three positive for IgM. The DENV seropositive rates were: IgG, 4·2% (34/819, 95%CI: 2·8-5·6%) and IgM, 0·4% (3/819, 95%CI: 0-0·8%). The demographic characteristics of 36 seropositive donors (one donor positive both for IgG and IgM) were similar to that of all the participated donors and no significant difference was found by gender, ethnicity and age. The DENV IgG rate was similar to the rate from donor samples collected in 2014 in the same area (3·4%, 51/1500) (Liao et al., 2017),